These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15983260)

  • 1. Interplay between apolipoprotein E and scavenger receptor class B type I controls coronary atherosclerosis and lifespan in the mouse.
    Fazio S; Linton MF
    Circulation; 2005 Jun; 111(25):3349-51. PubMed ID: 15983260
    [No Abstract]   [Full Text] [Related]  

  • 2. Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice.
    Zhang S; Picard MH; Vasile E; Zhu Y; Raffai RL; Weisgraber KH; Krieger M
    Circulation; 2005 Jun; 111(25):3457-64. PubMed ID: 15967843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
    J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytes are not required for the rapid onset of coronary heart disease in scavenger receptor class B type I/apolipoprotein E double knockout mice.
    Karackattu SL; Picard MH; Krieger M
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):803-8. PubMed ID: 15692099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic lipase deficiency delays atherosclerosis, myocardial infarction, and cardiac dysfunction and extends lifespan in SR-BI/apolipoprotein E double knockout mice.
    Karackattu SL; Trigatti B; Krieger M
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):548-54. PubMed ID: 16397139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scavenger Receptor Class B Type 1 Deletion Led to Coronary Atherosclerosis and Ischemic Heart Disease in Low-density Lipoprotein Receptor Knockout Mice on Modified Western-type Diet.
    Liao J; Guo X; Wang M; Dong C; Gao M; Wang H; Kayoumu A; Shen Q; Wang Y; Wang F; Huang W; Liu G
    J Atheroscler Thromb; 2017 Feb; 24(2):133-146. PubMed ID: 27373983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage apolipoprotein E reduces atherosclerosis and prevents premature death in apolipoprotein E and scavenger receptor-class BI double-knockout mice.
    Yu H; Zhang W; Yancey PG; Koury MJ; Zhang Y; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):150-6. PubMed ID: 16269665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
    Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
    J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E and atherosclerosis: beyond lipid effect.
    Davignon J
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):267-9. PubMed ID: 15681305
    [No Abstract]   [Full Text] [Related]  

  • 10. Morphologic and electroretinographic phenotype of SR-BI knockout mice after a long-term atherogenic diet.
    Provost AC; Vede L; Bigot K; Keller N; Tailleux A; Jaïs JP; Savoldelli M; Ameqrane I; Lacassagne E; Legeais JM; Staels B; Menasche M; Mallat Z; Behar-Cohen F; Abitbol M
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3931-42. PubMed ID: 19420333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
    Desai A; Zhao Y; Warren JS
    Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal platelet reactivity in apolipoprotein E (apo E)-deficient mouse.
    Nofer JR; Brodde M; Herminghaus G; Seedorf U; Assmann G; Kehrel BE
    Platelets; 2006 Nov; 17(7):498-500. PubMed ID: 17074727
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
    Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
    Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage.
    Li K; Yao W; Zheng X; Liao K
    Cell Res; 2009 Aug; 19(8):1006-17. PubMed ID: 19546885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis.
    Aslanian AM; Charo IF
    Circulation; 2006 Aug; 114(6):583-90. PubMed ID: 16880330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of urokinase plasminogen activator promotes progression and instability of atherosclerotic lesions in apolipoprotein E-knockout mice.
    Dellas C; Schremmer C; Hasenfuss G; Konstantinides SV; Schäfer K
    Thromb Haemost; 2007 Jul; 98(1):220-7. PubMed ID: 17598016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E polymorphism, age and coronary heart disease.
    Kolovou GD; Anagnostopoulou KK
    Ageing Res Rev; 2007 Aug; 6(2):94-108. PubMed ID: 17224309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice.
    Xu X; Gao X; Potter BJ; Cao JM; Zhang C
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):871-7. PubMed ID: 17272755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.